PDR: A New Anti-VEGF Era?
Available from: 11/12/2018
Where to publish: www.mivision.com.au and mieducation.com
Provider: Mivision
Contact: Nikki Byrne, [E] nikki@mivision.com.au, [P] 02 8336 8616
Learning Objectives
- How to diagnose proliferative diabetic retinopathy
- The prevalence and epidemiology of proliferative diabetic retinopathy
- The risk factors for proliferative diabetic retinopathy
- The clinical features of proliferative diabetic retinopathy and that this is an eye-threatening disease
- Ocular and systemic investigations required for proliferative diabetic retinopathy. Ocular investigations to be discussed include: optical coherence tomography, fluorescein angiography and OCT-angiography.
- That both ocular and systemic management is required for the treatment of proliferative diabetic retinopathy. That the mainstay of ocular management is panretinal photocoagulation, although intra-vitreal anti-VEGF therapy may also have a role.
- The indications for performing vitrectomy surgery in patients with proliferative diabetic retinopathy
Max points awarded: 2.00
Session Information
| Name |
|---|
| PDR: A New Anti-VEGF Era? |
| Activity Type |
| Independent Learning with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 2.00 |
| Name | Activity Type | Therapeutic? | Manufacturer/ Supplier? | Points for attending & Passing Assessment |
|---|---|---|---|---|
| PDR: A New Anti-VEGF Era? | Independent Learning with Assessment | No | No | 2.00 |